Seer Chief Executive Officer and Chair Omid Farokhzad offered to buy the company for $2.45 a share in cash, plus two contingent value rights. Shares surged 39%, to $2.25, after the bell on Thursday.
Orthofix Medical said Medicare reimbursement rates are being restored to original levels following a reversal from the Centers for Medicare & Medicaid Services. The stock gained 7.9%, to $10.72, in after-hours trading.
Halozyme Therapeutics said its chief operating officer was leaving the company. Shares fell 3.1%, to $77.00.
Write to Elias Schisgall at elias.schisgall@wsj.com
(END) Dow Jones Newswires
July 02, 2026 18:57 ET (22:57 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.